PRESENTATION

MESSAGE FROM THE ORGANIZING COMMITTEE

GERAL

1 – REDUCTION IN OVERALL SURVIVAL OF WOMEN WITH METASTATIC BREAST CANCER IN LOW- AND MIDDLE-INCOME COUNTRIES: A REFLECTION OF LACK OF ACCESS?

3 – LEAN MASS IS INVERSELY ASSOCIATED WITH BREAST CANCER, WHILE ABDOMINAL ADIPOSITY AND INSULIN RESISTANCE INCREASES THE CHANCES OF DEVELOPING THE CANCER.

4 – ANALYSIS OF CLINICAL OUTCOMES BASED ON MOLECULAR SUBTYPES IN PATIENTS WITH BREAST CANCER THAT RECEIVED NEOADJUVANT CHEMOTHERAPY

5 – TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) .

6 – ONCOTYPE DX® IN THE SISTEMA ÚNICO DE SAÚDE DO BRASIL (SUS): RESULT OF 125 CASES

7 – FUNCTIONAL AND PROGNOSTIC ANALYSIS OF AGR2 (ANTERIOR GRADIENT PROTEIN 2) IN BREAST CANCER USING IN-SILIC DATA

8 – COMPARATIVE EFFECTIVENESS OF BREAST CONSERVING SURGERY VERSUS MASTECTOMY ON SURVIVAL IN BREAST CANCER PATIENTS THAT RECEIVED NEOADJUVANT CHEMOTHERAPY AND POST-OPERATIVE RADIATION THERAPY

9 – INFLUENCE OF THE SURGICAL CLIP ON BREAST, HEART AND LUNG VOLUMES OF PATIENTS SUBMITTED TO BOOST DURING THE PLANNING OF BREAST CANCER RADIOTHERAPY, ACCORDING TO ONCOPLASTIC SURGERY
10 – ONCOPLASTIC SURGERY IN BREASTCONSERVATIVE TREATMENT: PATIENT PROFILE AND IMPACT ON QUALITY OF LIFE

11 – COSMETIC OUTCOMES IN BREAST ONCOPLASTY: RETROSPECTIVE COHORT TO COMPARE OBJECTIVE AND SUBJECTIVE METHODS OF EVALUATION

12 – REGIONAL DIFERENCES OF BREAST CANCER RECONSTRUCTIVE SURGERIES AMONG BRAZIL´S PUBLIC HEALTHCARE USERS: A 10 YEAR STUDY

13 – ONCOPLASTIC MAMMAPLASTY WITH GEOMETRIC COMPENSATION – OUTCOMES AND FOLLOW-UP OF A MULTICENTRIC PROSPECTIVE COHORT

14 – LIRAGLUTIDE AS A NOVEL DNA DEMETHYLATING AGENT AND ITS POTENTIAL USE IN THE ADJUVANT TREATMENT OF HIGLY INVASIVE BREAST CANCER 

15 – FACTORS ASSOCIATED WITH RETURN TO WORK OF BREAST CANCER SURVIVORS TREATED AT THE PUBLIC CANCER HOSPITAL IN BRAZIL

16 –  RECIST EVALUATION OF THE USE OF SALVAGE  RADIOTHERAPY IN LOCALLY ADVANCED BREAST CANCER REFRACTORY TO NEOADJUVANT CHEMOTHERAPY AND UNRESECTABLE

 

COMMENTED POSTER

17 – INFLUENCE OF LIFESTYLE FACTORS ON BREAST CANCER RISK: A CASE-CONTROL STUDY WITH A REPRESENTATIVE SAMPLE OF THE BRAZILIAN POPULATION

18 – TRENDS IN THE INCIDENCE OF BREAST CANCER FOLLOWING THE RADIOLOGICAL ACCIDENT IN GOIÂNIA: A 25-YEAR ANALYSIS 

19 – AXILLARY SURGICAL APPROACH IN METASTATIC BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

20 – GEOMETRIC COMPENSATION TECHNIQUE FOR BREAST CONSERVATIVE TREATMENT: EXPANDING THE INDICATIONS AND COSMETIC EVALUATION

21 – FIRST STUDY OF THE PREVALENCE OF THE TP53 P.R337H MUTATION IN BREAST CANCER PATIENTS IN THE CENTRAL REGION OF BRAZIL 

22 – REAL WORLD DATA ON PATIENT PROFILES AND PATTERNS OF CARE IN DE NOVO METASTATIC BREAST CANCER: AN ANALYSIS OF 17 YEARS (1995–2011)

23 – OVERALL SURVIVAL INCREASE AFTER TREATMENT OF BRAIN METASTASIS FOR HER-2 POSITIVE PATIENTS USING TRASTUZUMAB

24 – EFFECT OF NUTRITIONAL STATUS ON HEALTHRELATED QUALITY OF LIFE (HRQL) THROUGHOUT CHEMOTHERAPY: A PROSPECTIVE STUDY

25 – ANALYSIS OF EPIGENETIC MOLECULES SIRT2 E SIRT6 IN BREAST CANCER SUBTYPES 

26 – PLASMA BIOMARKERS OF SYSTEMIC REDOX STATUS: A POTENTIAL PREDITOR OF CHEMOTHERAPY. EFFICACY IN WOMEN WITH BREAST CANCER

27 – ATTENUATED TOTAL REFLECTION-FOURIER TRANSFORM INFRARED (ATR-FTIR) SPECTROSCOPY ANALYSIS OF SALIVA FOR BREAST CANCER DIAGNOSIS

28 – COMPARISON OF THE ANTIPROLIFERATIVE ACTIVITY OF DIFFERENT EXTRACTS FROM POTHOMORPHE UMBELLATA IN BREAST CANCER CELL LINES

29 – POTENTIAL APPLICATION OF A SEROLOGICAL SPECTRAL BIOMARKER FOR ALTERNATIVE DIAGNOSIS OF BREAST CANCER

30 – REGIONAL DIFERENCES OF BREAST CANCER SURGERIES AMONG BRAZIL´S PUBLIC HELTHCARE USERS: A 10-YEAR STUDY

31 – INVASIVE APPROACHES IN BENIGN BREAST TUMORS IN BRAZIL

E-POSTER

32 – TELOMERASE POLYMORPHISM AND BREAST CANCER

33 – BARRIERS RELATED TO MAMMOGRAPHY IN THE RIVERSIDE POPULATION OF THE BRAZILIAN AMAZON: CASE-CONTROL STUDY

34 – BRINGING PATIENT NAVIGATION TO PRIMARY HEALTH CARE IN RIO DE JANEIRO: PILOT PROJECT IN THE ANDARAÍ COMMUNITY

35 – PREDICTION OF ATTENDANCE TO THE “60 DAYS LAW” WITHIN THE PATIENT NAVIGATION PROGRAM TO BREAST CANCER IN RIO DE JANEIRO

36  – STRATEGIES OF GUIDELINES IMPLEMENTATION FOR THE BREAST CANCER EARLY DETECTION IN BRAZIL

37 – SEXUAL DYSFUNCTION AMONG WOMEN WITH BREAST CANCER DIAGNOSTIC: DESCRIPTIVE STUDY

38 – MICRO-RNA 21 ACTING AS AN ONCOMIR ON HER2 POSITIVE BREAST CANCER: A META-ANALYSIS

39 – BREAST CANCER SURVIVAL: A HOSPITAL REGISTRY-BASED RETROSPECTIVE COHORT OF SÃO PAULO, BRAZIL

40 – IS SENTINEL LYMPH NODE BIOPSY SAFE FOR T3 AND T4 BREAST TUMORS? ANALYSIS OF A INSTITUTIONAL CASE SERIES AND SYSTEMATIC LITERATURE REVIEW

41 – STANDARD BREAST-CONSERVING VERSUS ONCOPLASTIC SURGERY: A LOCOREGIONAL RECURRENCE COMPARISON

42 – FIRST BRAZILIAN EXPERIENCE WITH VACUUMASSISTED BREAST BIOPSIES GUIDED BY PRONE TOMOSYNTHESIS: 197 CASES

43 – HIGHER PRO-INFLAMMATORY DIET AND WORSE NUTRITIONAL STATUS DURING CHEMOTHERAPY: A PROSPECTIVE STUDY WITH BREAST CANCER WOMEN

44 – EATING LATE AND LESS FREQUENTLY HAS A NEGATIVE IMPACT ON THE DIET QUALITY OF BREAST CANCER WOMEN UNDERGOING ENDOCRINE THERAPY

45 – BILATERAL BREAST RECONSTRUCTION SURGERY: ECONOMIC PERSPECTIVES AND IMPLICATIONS ON THE QUALITY OF LIFE OF PATIENTS SUBMITTED TO UNILATERAL BREAST CANCER MASTECTOMY

46 – QUALITY OF LIFE AND AESTHETIC SATISFACTION OF BREAST CANCER PATIENTS SUBMITTED TO NEOADJUVANT CHEMOTHERAPY AND SURGERY WITH OR WITHOUT IMMEDIATE RECONSTRUCTION

47 – ANALYSIS OF THE PREVALENCE OF THE C.156_157INSALU PATHOGENIC VARIANT IN BRCA2 GENE IN CENTRAL BRAZIL PATIENTS WITH SUSPECTED HEREDITARY BREAST AND OVARY CANCER SYNDROME (HBOC)

48 – INSTRUCTION LEVEL AND SKIN COLOR EXPRESSED IN MAMMOGRAMS IN THE STATE OF GOIÁS IN 2013

49 – CLINICAL AND MOLECULAR EVALUATION OF MICROCALCIFICATIONS CLASSIFIED AS BIRADS® 4 AND 5

50 – PATIENTS WITH BREAST CANCER: CHANGES IN BODY IMAGE